Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Joint association of triglyceride-glucose index and atherogenic lipid markers with incident stroke risk.

Scientific reports·2026
Same author

Phosphorus application, nutrient absorption, and endophytic root bacterial communities in maize grown in phosphorus-deficient rocky arid soils, China.

Scientific reports·2026
Same author

Machine learning-driven clinical decision support for radical local consolidative therapy in synchronous oligometastatic NSCLC: A SEER population-based analysis of 17 cancer registries (2018-2021).

International journal of surgery (London, England)·2025
Same author

Roles and mechanisms of piRNAs in self-renewal and differentiation of germline stem cells.

Differentiation; research in biological diversity·2025
Same author

Barley young leaf chlorina, a putative pentatricopeptide repeat gene, is essential for chloroplast development in young leaves.

Plant molecular biology·2025
Same author

Visualization of liquid-liquid phase transitions using a tiny G-quadruplex binding protein.

bioRxiv : the preprint server for biology·2024
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
09:08

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

Published on: September 12, 2016

7.7K

Sample size consideration for immunoassay screening cut-point determination.

Jianchun Zhang1, Lanju Zhang, Harry Yang

  • 1a MedImmune LLC , Gaithersburg , Maryland , USA.

Journal of Biopharmaceutical Statistics
|April 5, 2014
PubMed
Summary
This summary is machine-generated.

Determining the sample size for immunoassays is crucial for accurate cut point determination. This study introduces a systematic approach and helpful tables to guide scientists in sample size calculations for robust immunogenicity assays.

Keywords:
ANOVAAntidrug antibodyCut pointImmunogenicitySample sizeVariance component model

More Related Videos

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

9.5K
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

10.9K

Related Experiment Videos

Last Updated: May 1, 2026

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
09:08

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens

Published on: September 12, 2016

7.7K
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

9.5K
Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method
09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

10.9K

Area of Science:

  • Biopharmaceutical Development
  • Immunology
  • Assay Validation

Background:

  • Biopharmaceutical products are rapidly increasing, necessitating robust immunogenicity assessment.
  • Antidrug antibodies from biopharmaceuticals can cause adverse immune reactions.
  • Regulatory agencies require validated assays for immunogenicity testing.

Purpose of the Study:

  • To address the lack of clear guidelines for sample size determination in immunoassay validation.
  • To propose a systematic methodology for calculating the required sample size for immunoassays.
  • To provide practical tools, such as tables, for scientists to apply these methods.

Main Methods:

  • Reviewing current practices and limitations in immunoassay sample size determination.
  • Developing a systematic approach based on statistical principles for sample size calculation.
  • Generating tables to simplify the application of the proposed methodology.

Main Results:

  • A structured framework for determining sample size in immunoassays has been established.
  • The proposed method aims to ensure precise cut point determination.
  • The provided tables offer practical guidance for assay development scientists.

Conclusions:

  • A systematic approach to sample size determination is essential for reliable immunoassay validation.
  • Implementing this methodology will enhance the precision of cut point determination.
  • The study provides valuable resources for scientists working with immunogenicity assays.